These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20574069)

  • 1. Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates.
    Tucker EI; Marzec UM; Berny MA; Hurst S; Bunting S; McCarty OJ; Gruber A; Hanson SR
    Sci Transl Med; 2010 Jun; 2(37):37ra45. PubMed ID: 20574069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates.
    Harker LA; Hunt P; Marzec UM; Kelly AB; Tomer A; Hanson SR; Stead RB
    Blood; 1996 Mar; 87(5):1833-44. PubMed ID: 8634430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB; Chronos NR; Sundell IB; Hanson SR; Herbert JM
    Circulation; 1998 Dec; 98(22):2461-9. PubMed ID: 9832493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.
    Hanson SR; Pareti FI; Ruggeri ZM; Marzec UM; Kunicki TJ; Montgomery RR; Zimmerman TS; Harker LA
    J Clin Invest; 1988 Jan; 81(1):149-58. PubMed ID: 2961790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons.
    Lumsden AB; Kelly AB; Schneider PA; Krupski WC; Dodson T; Hanson SR; Harker LA
    Blood; 1993 Apr; 81(7):1762-70. PubMed ID: 8461462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB
    Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates.
    Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR
    Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody-induced inhibition of platelet function: effects on hemostasis and vascular graft thrombosis in baboons.
    Torem S; Schneider PA; Hanson SR
    J Vasc Surg; 1988 Jan; 7(1):172-80. PubMed ID: 3336123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized antithrombotic therapy.
    Lüscher TF; Steffel J
    Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticlopidine inhibits the prothrombotic effects of thrombopoietin and ameliorates survival after supralethal total body irradiation.
    Mouthon MA; Gaugler MH; Vandamme M; Gourmelon P; Wagemaker G; Van der Meeren A
    Thromb Haemost; 2002 Feb; 87(2):323-8. PubMed ID: 11858494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion, decreases platelet aggregation and intimal hyperplasia in a rat carotid endarterectomy model.
    Cruz CP; Eidt J; Drouilhet J; Brown AT; Wang Y; Barnes CS; Moursi MM
    J Vasc Surg; 2001 Oct; 34(4):724-9. PubMed ID: 11668330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates.
    Cadroy Y; Hanson SR; Kelly AB; Marzec UM; Evatt BL; Kunicki TJ; Montgomery RR; Harker LA
    Blood; 1994 Jun; 83(11):3218-24. PubMed ID: 8193356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.
    Imura Y; Stassen JM; Vreys I; Lesaffre E; Gold HK; Collen D
    Thromb Haemost; 1992 Sep; 68(3):336-40. PubMed ID: 1440501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
    Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.
    Coccheri S
    Drugs; 2010 May; 70(7):887-908. PubMed ID: 20426498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-hour antiplatelet effect of aspirin in patients with previous definite stent thrombosis.
    Würtz M; Hvas AM; Jensen LO; Kaltoft AK; Tilsted HH; Kristensen SD; Grove EL
    Int J Cardiol; 2014 Aug; 175(2):274-9. PubMed ID: 24861258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice.
    Shirai T; Revenko AS; Tibbitts J; Ngo ATP; Mitrugno A; Healy LD; Johnson J; Tucker EI; Hinds MT; Coussens LM; McCarty OJT; Monia BP; Gruber A
    Blood Adv; 2019 Oct; 3(20):3080-3091. PubMed ID: 31648335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant leech antiplatelet protein prevents collagen-mediated platelet aggregation but not collagen graft thrombosis in baboons.
    Schaffer LW; Davidson JT; Siegl PK; Gould RJ; Nutt RF; Brady SF; Connolly TM
    Arterioscler Thromb; 1993 Nov; 13(11):1593-601. PubMed ID: 8218100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of arterial thrombosis by edoxaban, an oral factor Xa inhibitor in rats: monotherapy and in combination with antiplatelet agents.
    Honda Y; Kamisato C; Morishima Y
    Eur J Pharmacol; 2016 Sep; 786():246-252. PubMed ID: 27288116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.